These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27285532)

  • 1. Random-effects meta-analysis for systematic reviews of phase I clinical trials: Rare events and missing data.
    Kim MO; Wang X; Liu C; Dorris K; Fouladi M; Song S
    Res Synth Methods; 2017 Jun; 8(2):124-135. PubMed ID: 27285532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review.
    Weir CJ; Butcher I; Assi V; Lewis SC; Murray GD; Langhorne P; Brady MC
    BMC Med Res Methodol; 2018 Mar; 18(1):25. PubMed ID: 29514597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian robustness in meta-analysis for studies with zero responses.
    Vázquez FJ; Moreno E; Negrín MA; Martel M
    Pharm Stat; 2016 May; 15(3):230-7. PubMed ID: 26913715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tutorial on Bayesian bivariate meta-analysis of mixed binary-continuous outcomes with missing treatment effects.
    Gajic-Veljanoski O; Cheung AM; Bayoumi AM; Tomlinson G
    Stat Med; 2016 May; 35(12):2092-108. PubMed ID: 26553369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random-effects meta-analysis of few studies involving rare events.
    Günhan BK; Röver C; Friede T
    Res Synth Methods; 2020 Jan; 11(1):74-90. PubMed ID: 31348846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian meta-analyses for comparative effectiveness and informing coverage decisions.
    Berry SM; Ishak KJ; Luce BR; Berry DA
    Med Care; 2010 Jun; 48(6 Suppl):S137-44. PubMed ID: 20473185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian sensitivity study of risk difference in the meta-analysis of binary outcomes from sparse data.
    Vázquez-Polo FJ; Moreno E; Negrín MA; Martel M
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):317-22. PubMed ID: 25673174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian approach to sequential meta-analysis.
    Spence GT; Steinsaltz D; Fanshawe TR
    Stat Med; 2016 Dec; 35(29):5356-5375. PubMed ID: 27481499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian survival analysis in clinical trials: What methods are used in practice?
    Brard C; Le Teuff G; Le Deley MC; Hampson LV
    Clin Trials; 2017 Feb; 14(1):78-87. PubMed ID: 27729499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An empirical comparison of Bayesian modelling strategies for missing binary outcome data in network meta-analysis.
    Spineli LM
    BMC Med Res Methodol; 2019 Apr; 19(1):86. PubMed ID: 31018836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian approach to meta-analysis of plant pathology studies.
    Mila AL; Ngugi HK
    Phytopathology; 2011 Jan; 101(1):42-51. PubMed ID: 20822433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flexible mixed-effect negative binomial regression model for detecting unusual increases in MRI lesion counts in individual multiple sclerosis patients.
    Kondo Y; Zhao Y; Petkau J
    Stat Med; 2015 Jun; 34(13):2165-80. PubMed ID: 25784219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods.
    White IR; Higgins JP; Wood AM
    Stat Med; 2008 Feb; 27(5):711-27. PubMed ID: 17703496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
    Odani M; Fukimbara S; Sato T
    Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
    Hart B; Lundh A; Bero L
    BMJ; 2012 Jan; 344():d7202. PubMed ID: 22214754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of aggregate data on medical events.
    Holzhauer B
    Stat Med; 2017 Feb; 36(5):723-737. PubMed ID: 27859465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we rely on the best trial? A comparison of individual trials and systematic reviews.
    Glasziou PP; Shepperd S; Brassey J
    BMC Med Res Methodol; 2010 Mar; 10():23. PubMed ID: 20298582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian hierarchical models for network meta-analysis incorporating nonignorable missingness.
    Zhang J; Chu H; Hong H; Virnig BA; Carlin BP
    Stat Methods Med Res; 2017 Oct; 26(5):2227-2243. PubMed ID: 26220535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.